Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial-Reference-Cited by-同舟云学术

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial

Published:2016-06 Issue:6 Volume:17 Page:747-756
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Carrie Christian,Hasbini Ali,de Laroche Guy,Richaud Pierre,Guerif Stéphane,Latorzeff Igor,Supiot Stéphane,Bosset Mathieu,Lagrange Jean-Léon,Beckendorf Véronique,Lesaunier François,Dubray Bernard,Wagner Jean-Philippe,N'Guyen Tan Dat,Suchaud Jean-Philippe,Créhange Gilles,Barbier Nicolas,Habibian Muriel,Ferlay Céline,Fourneret Philippe,Ruffion Alain,Dussart Sophie

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

2. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up;Antonarakis;BJU Int,2012

3. Radiation therapy after radical prostatectomy: impact on metastasis and survival;Boorjian;J Urol,2009

4. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis;Briganti;Eur Urol,2012

5. Salvage radiotherapy for patients with PSA relapse following radical prostatectomy: issues and challenges;Choo;Cancer Res Treat,2010

Cited by 326 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives;Clinical Genitourinary Cancer;2024-10

2. Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis;Prostate Cancer and Prostatic Diseases;2024-09-13

3. Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review;European Urology;2024-09

4. Delayed definitive management of localized prostate cancer: what do we know?;Prostate Cancer and Prostatic Diseases;2024-08-11

5. A randomised trial of short‐ vs long‐term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06‐24;BJU International;2024-07-23